本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEPPU, Japan, March 26, 2025 /PRNewswire/ -- The "Mixed Bathing World Executive Committee" based in Beppu City, Oita Prefecture, southeastern Japan, has just installed its two latest artworks in "ALTERNATIVE-STATE," an art project that started in 2022 to enhance the hot spa-rich city's brand loyalty. As one of the world's leading hot spring resorts, Beppu not only boasts a unique culture centered around hot spas, and with them the evocative image of steam rising mysteriously from the earth, but also is proving itself as a hub in the art world, with both local and overseas artistic endeavors gaining steady attention. The combination of these two points of appeal -- natural hot springs and the world of art -- makes Beppu a truly unique travel destination. Photo1: Yukemuri (steam rising from hot springs) https://cdn.kyodonewsprwire.jp/prwfile/release/M107359/202503185886/_prw_PI2fl_1O38wk0B.jpg "ALTERNATIVE-STATE" is an art project started in 2022 to enhance the city's brand loyalty and organized by the "Mixed Bathing World Executive Committee" based in Beppu. Installing art pieces throughout the city, ALTERNATIVE-STATE invites artists from all over the world, from virtuosos to the up-and-coming, to participate in its goal of installing eight works of art in a four-year period. Introduced below are two newly installed artworks. #5 Bluebird Sign This work is a dispersed installation, inviting viewers to explore the downtown area of Beppu. It consists of stories created from interviews with people who live in this town. As if searching for a bluebird, visitors can look for the artworks scattered throughout the daily life and savor the town's scenery and the stories. Photo2: Bluebird Sign https://cdn.kyodonewsprwire.jp/prwfile/release/M107359/202503185886/_prw_PI3fl_5K6oPf4J.jpg #7 Distorted "JIKU" #023D-1 / BEPPU A single ray of light appears in the sky above the main street in front of Beppu Station after sunset. This is an artwork that makes visible the unique historical or geographical axis of a locality. Photo3: Distorted "JIKU" #023D-1 / BEPPU https://cdn.kyodonewsprwire.jp/prwfile/release/M107359/202503185886/_prw_PI1fl_VhBnhPLk.jpg About Beppu City, Oita Prefecture Beppu is home to a number of additional art spots dotted throughout town. What's more, every autumn Beppu will be not only Art Fair Beppu, where visitors have the chance to meet up-and-coming artists from September 27 (Sat.) to 29 (Mon.), 2025, but also a venue of Beppu Art Month -- a cultural art festival that takes place all over the city from September 27 (Sat.) to November 16 (Sun.), 2025. Photos from Art Fair Beppu 2024: https://cdn.kyodonewsprwire.jp/prwfile/release/M107359/202503185886/_prw_PI4fl_Br2Pn20L.jpg https://cdn.kyodonewsprwire.jp/prwfile/release/M107359/202503185886/_prw_PI5fl_Px5C3P90.jpg ALTERNATIVE-STATE https://alternative-state.com/?lang=en Art Fair Beppu https://artfairbeppu.com Beppu Art Month https://www.beppuartmonth.com Tourist Information WANDER COMPASS BEPPU https://wandercompass.jp/beppu
TOKYO, March 26, 2025 /PRNewswire/ -- Sungrow, a global leading PV inverter and energy storage system provider, has officially announced that its residential energy storage system has obtained JET (Japan Electrical Safety & Environment Technology Laboratories) certification. The certified products include the SH5.5RS-JP hybrid inverter and residential battery, with a maximum storage capacity of 12.8 kWh. Sungrow Residential Energy Storage System Earns JET Certification Building on the JET certification of Sungrow's low-voltage products in 2024 (Sungrow Secures JET Certification for SG5.5RS-JP, Reinforcing Commitment to Excellence in Japan | SUNGROW), this achievement marks another significant milestone in Sungrow's expansion in Japan market, reaffirming its technological strength and competitive edge in the energy storage sector. Optimized Energy Utilization for Lower Household Electricity Costs As electricity prices in Japan continuing to rise, household energy expenses have become a growing concern. Sungrow's residential storage system features multiple operation modes, enabling the efficient use of solar power to reduce electricity costs and support sustainable energy consumption. Smart Energy Management - Stores excess solar power generated during the daytime for nighttime use, minimizing reliance on purchased electricity. Time-of-Use Optimization - Charges during off-peak hours and discharges during peak demand periods, optimizing household energy consumption and costs. Enhanced Energy Security - Includes an automatic off-grid mode to ensure a stable power supply in case of grid outages and enhance household energy security. JET Certification: A Testament to Safety and Reliability JET certification is one of the most prestigious electrical safety certifications in Japan, requiring products to meet rigorous technical and safety standards. By obtaining this certification, Sungrow's residential storage system has demonstrated its high safety, reliability, and superior performance, providing Japanese consumers with a trustworthy and efficient clean energy solution. Commitment to a Greener Future Looking ahead, Sungrow remains committed to further developing and enhancing its products in the Japanese market, advancing intelligent energy storage technologies, and promoting the adoption of green energy solutions for a more sustainable future. About Sungrow Sungrow, a global leader in renewable energy technology, has pioneered sustainable power solutions for over 28 years. As of December 2024, Sungrow has installed 740 GW of power electronic converters worldwide. The Company is recognized as the world's No. 1 on PV inverter shipments (S&P Global Commodity Insights) and the world's most bankable energy storage company (BloombergNEF). Its innovations power clean energy projects in over 180 countries, supported by a network of 520 service outlets guaranteeing excellent customer experience. At Sungrow, we're committed to bridging to a sustainable future through cutting-edge technology and unparalleled service. For more information, please visit: www.sungrowpower.com.
NINGBO, China, March 26, 2025 /PRNewswire/ -- As the photovoltaic industry accelerates into the n-type era, Heterojunction (HJT) technology is reshaping the landscape with its empirical performance. Winter data from Ningbo empirical power station of Risen Energy reveal that HJT modules achieve a 3.85% higher single-watt power generation than BC modules, with a peak daily gain of 9.97%. These findings highlight the superior power generation capabilities of HJT technology. 【Unveiling High Efficiency Through Rigorous Empirical Validation】The Ningbo empirical power station experiences an average annual irradiance of 1268 kWh/m² and an average temperature of approximately 15°C, with extremes ranging from a high of 39°C to a low of -2°C. The site has an average annual relative humidity of 79% and is classified as a northern subtropical humid monsoon climate. For this empirical project, 210 HJT and 182 BC modules were installed vertically on fixed racks at a 15° tilt angle and a height of 1.5 m above the ground. A high-precision outdoor photovoltaic module evaluation system, featuring millisecond-level IV curve tracking technology with an error rate of <0.5%, was employed. This system accurately tracked the MPPT maximum power point and real-time IV curves, offering a precise and intuitive assessment of the modules' real-time power generation performance. 【Superior Power Generation Driven by High-Performance Heterojunction Technology】 Bifacial Advantage: 90%+ Backside Gain Maximizes Energy Yield HJT modules demonstrate a significant power generation advantage in high-reflectance environments such as snow and sand, achieving a backside gain of 90%—20% higher than BC modules (≤70%). For every 1% increase in bifaciality, system power generation increases by approximately 0.12% to 0.15%. This 20% gap translates to a stable gain of 2.4% to 3.0%. -0.24%/°C Ultra-Low Temperature Coefficient: Enhancing Power Generation in High-Temperature Conditions With a temperature coefficient of -0.24%/°C, HJT modules are 7.7% less affected by temperature compared to BC modules, which have a coefficient of -0.26%/°C. Third-party empirical testing shows a daily power generation increase of 1.2% to 1.8% during the high-temperature season. Red Light Band Response Boosts Power Generation in the Morning and Evening The use of high-mobility target materials and the advanced structural design of HJT solar cells enhance their sensitivity to the red light band, resulting in longer power generation durations and greater benefits for customers. These core advantages not only deliver excess green electricity returns throughout the power station's lifecycle but also provide empirical data that validates the superior power generation of HJT technology. This redefines the value benchmark of photovoltaic technology. As n-type technology continues to gain momentum, Risen's HJT modules will drive the industry's shift from a 'cost priority' to an 'efficiency priority,' contributing greater certainty to the global energy transition. Data Sources: [1] Ningbo Empirical Power Station 2024-2025 Winter Monitoring Report;[2] IEC61853-1:2019 Photovoltaic Module Power Temperature Coefficient Measurement and Rating Part 1: Irradiance and Temperature Performance Measurement and Power Calibration.
South Australian Local Council, City of Playford, installs solar on six key buildings; delivering on ESG goals ADELAIDE, Australia, March 26, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart PV and energy storage, has partnered with Venergy Solar to deliver a multibuild solar installation across the City of Playford. Six key council buildings have enhanced their green energy credentials by installing solar across their rooftops, providing long-term energy savings and reinforcing the council's commitment to driving clean energy in the region. Shedley Theatre, featuring Trinasolar's Vertex S+ modules. Credit: Venergy Solar Australia The large-scale rooftop rollout covers theatres, sports clubs, and carparks, totalling 202kW of installed capacity, reducing the council's reliance on grid electricity and cutting carbon emissions. The project underscores Playford's forward-thinking approach to sustainability and its ability to leverage technology to achieve clean energy goals, while ensuring responsible procurement practices aligning with stringent environmental, social, and governance (ESG) standards. Jonathan Roberts, Senior Manager Asset Operations at the City of Playford, commended the project's positive impact on the community, "This initiative aligns with our vision for a greener, more sustainable Playford. By investing in renewable energy, we are not only reducing costs but also demonstrating environmental leadership that benefits our broader community." Delivered by Venergy, a trusted provider of renewable energy solutions, the project saw the integration of Trinasolar's high-performance Vertex S+ modules across all six sites. Matthew Wilkins, CEO of Venergy, highlighted the project's success in meeting the council's energy goals. "Venergy is proud to have played a key role in this landmark project, ensuring high-quality solar solutions were installed efficiently and effectively. Trinasolar modules were chosen for their industry-leading efficiency, durability, and long-term performance, ensuring maximum energy output for the City of Playford," said Wilkins. Trinasolar, a global leader in solar technology, supplied the high-efficiency Vertex S+ 500W (NEG18R.20) monofacial dual glass modules for the project. The selection of Trinasolar was not only driven by the high performance of its modules, due to its cutting-edge n-type i-TOPCon cell technology, but also by the company's strong ESG credentials. The City of Playford prioritised sustainability throughout the procurement process, ensuring that every component of this project aligned with its strict ESG standards. Responsible procurement was a key priority, with a focus on sourcing from manufacturers that uphold sustainability, transparency, and ethical production practices. Trinasolar's commitment to low-carbon solar module production aligned perfectly with these stringent ESG requirements, ensuring that the environmental benefits of this project extend beyond energy generation to responsible and ethical manufacturing. Edison Zhou, Head of Australia and New Zealand at Trinasolar, emphasised the company's dedication to delivering reliable and environmentally responsible solar solutions. "We are delighted to partner with Venergy and the City of Playford to power critical community infrastructure with clean energy. We view sustainability as a key competitive advantage and are committed to supporting Australian councils and businesses with high-quality, efficient solar technology driving both long-term sustainability and cost savings. Our low-carbon manufacturing process ensures that our modules contribute to a cleaner future not just in their energy generation, but in their entire lifecycle ," said Zhou. The project included installations at key locations such as the Virginia Horticultural Centre, Shedley Theatre, Uley Road Hall, Windsor Carpark, The Precinct, and Angle Vale Sports Club. These solar systems will not only reduce operational costs for the council but also serve as a model for other municipalities looking to implement large-scale renewable energy solutions while adhering to best-practice ESG principles.
TOKYO, March 26, 2025 /PRNewswire/ -- FY25 marks our 140th anniversary and the final year of our current Medium-Term Management Plan (MTMP). As we reach this milestone, we are reaffirming our commitment to continuous corporate value enhancement. Since FY20, our PBR had been below 1.0x, and with our profit outlook for FY24, we recognize that there are concerns from investors about achieving an ROE of 8% in the next fiscal year. We recognize the importance of addressing these concerns with urgency. Since the announcement of current MTMP, we have accelerated our efforts to enhance corporate value. On January 31, we clearly committed to achieving a ROE of 8% in FY25 and demonstrated our willingness to aim for an ROE exceeding 10% around FY30. Capital efficiency is the core financial metric that our team uses and we believe shareholders should also use to evaluate our financial performance over time. We promised to present our key themes for the next MTMP by the end of March, and we are committed to prioritizing dialogue with stakeholders as we formulate our next MTMP. Achieving high ROE targets is not an easy task for a company like ours, which is required to hold a significant amount of assets to be able to provide stable infrastructure services. However, we believe we can achieve these targets by leveraging our solid domestic customer base and assets to enhance the profitability and asset value of our existing businesses. Additionally, we believe expanding into adjacent and interconnecting our businesses to create new value will better position us to achieve our targets. Domestically, we aim to increase corporate value by cross-selling gas, electricity, and solutions to our customer base, further strengthening the customer base itself, and converting existing real estate assets in our urban development business, integrating building and energy system development/operation. Internationally, we will focus on ensuring profitability in our shale gas business while expanding into mid/downstream operations in the U.S. and LNG trading. Furthermore, strengthening resilience of existing infrastructure and working towards carbon neutrality are also crucial missions that support these efforts. Growth investments are essential for continuous value creation, and we are strengthening our investment discipline and elevating our investment strategies. For example, in the shale gas business, we learned from past experiences to invest in a US shale company with management familiar with local operations, strengthen governance, and gradually acquire a majority stake. This has allowed us to execute advanced area strategies and expansion investments. As a result, our shale gas business is expected to become a major profit pillar in FY25. Under the current MTMP, our financial strategy, which is instrumental for our growth, includes a highly flexible capital return policy. This policy includes a baseline target total return ratio of 40%, with room for opportunistic increases beyond that target as appropriate. To maintain capital efficiency, we are conducting significant share buybacks in FY25, as we did in FY24, to reverse the increase in equity from strong performance over the past two years to appropriate levels. We aim to enhance corporate value through this dual approach of steady growth investments and appropriate capital policies. With this announcement, we hope to convey our plan to deliver continuous corporate value enhancement, earning the trust of our multiple stakeholders and securing your support over the medium- to long-term. Media ContactsKekst CNC In Tokyo:Ai Saitoai.saito@kekstcnc.com In New York:Nick Capuanonicholas.capuano@kekstcnc.com
SINGAPORE, March 26, 2025 /PRNewswire/ -- Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. The company's innovative SPOT-MAS test has become the first multi-cancer screening blood test in Asia to complete large prospective cohort validation, as published in BMC Medicine. This milestone marks a major advancement, enabling large-scale, non-invasive early detection. Gene Solutions Leads the Way in Cancer Early Detection with Asia’s First Clinical Validated Multi-Cancer Blood Test Addressing a Critical Need Common cancers like breast and colorectal have survival rates greater than 90% if detected early (1). However, over 70% of cancers in low- and middle-income Asian countries are diagnosed at a late stage (2). Conventional image-based screening has limitations, including being invasive, less accessible, and focused on a single organ, which can lead to a high cumulative false positive rate when performed sequentially (3). SPOT-MAS aims to improve this by providing a reliable, non-invasive, multi-cancer blood test. The test incorporates next-generation sequencing (NGS) and artificial intelligence technologies to detect circulating tumor DNA (ctDNA) released from cancer cells into the bloodstream. Previously, SPOT-MAS established laboratory technology and analytical validation from 2018 to 2021. From 2022 to 2024, the SPOT-MAS test underwent the landmark K-DETEK Trial. This trial was the first and largest prospective cancer screening study in Asia, where 9,057 asymptomatic individuals were followed up for 12 months. After exclusions, 9,024 participants were analyzed, with 42.27% classified as high-risk due to factors such as smoking, alcohol consumption, and hepatitis virus infection. The Third Worldwide and the First Clinically Validated Multi-Cancer Early Detection (MCED) Test in Asia: While two other MCED tests have undergone prospective validation in the United States, the K-DETEK trial uniquely offers clinical data tailored to the Asian population. Despite the high expectations surrounding MCED tests worldwide, one of the most significant challenges is preserving performance when transitioning from controlled studies to real-world clinical validation. The SPOT-MAS test rises this challenge, demonstrating consistent performance across various validation studies. These include a case-control study with 2,288 participants published in eLife, the K-DETEK clinical trial with 9,024 participants published in BMC Medicine, and a real-world experience report of 10,577 tests conducted across Southeast Asia (Vietnam, Singapore, Malaysia, Thailand, Indonesia, and the Philippines) in ESMO Annals of Oncology (4,5,6). Additionally, the trial highlights the test's ability to detect precancerous lesions in the colon, offering opportunities for early intervention and active prevention of colorectal cancer. Remarkable Data from the Trial (5,7): High Sensitivity and Specificity: The SPOT-MAS assay demonstrated an overall sensitivity of 70.8% for cancerous lesions and 78.1% when combined with the assessment of precancerous lesions in the digestive tract, with a specificity of 99.7% for detecting various cancer types. Remarkable Predictive Value: The trial showed a positive predictive value of 39.53% for cancerous cases and 58.1% when including both cancerous and precancerous cases. The tumor origin prediction, based on the algorithm and machine learning model, had an accuracy of 52.9% for cancerous lesions and 84.0% when combined with precancerous lesions. The negative predictive value was an impressive 99.92%, ensuring accurate screening while minimizing unnecessary follow-ups. "SPOT-MAS is the first MCED test in Asia to provide real-world clinical evidence for cancer screening, offering the validation data needed for region-specific populations and demonstrating the test's clinical utility. We believe this important milestone will foster more discussions with regional healthcare experts to implement the test in routine medical screening programs." said MD. PhD. Nguyen Duy Sinh, Oncology Medical Director at Gene Solutions. Innovative Multi-Omics & Artificial Intelligence Approach Most MCED tests focus on a single circulating tumor DNA (ctDNA) biomarker detected through Next-Generation Sequencing technology. SPOT-MAS employs an innovative multi-omics analysis approach that integrates genetic, fragmentomic, and epigenetic features of ctDNA. This comprehensive strategy enhances cancer type coverage and improves real-world accuracy. The bioinformaticians behind the SPOT-MAS test leverage artificial intelligence (AI) to analyze the extensive data generated from these comprehensive features. By developing multiple machine learning, deep learning, and neural network models, they continuously train on labeled data from healthy individuals and cancer patients. This multi-modal AI technology further improves test sensitivity, accurately classifies cancer origins, and optimizes cost-efficiency for the multi-omics analysis approach. Future Innovations and Collaborations The SPOT-MAS test has demonstrated strong performance in detecting deadly cancers that lack standard screening options, such as cancers of the stomach, liver-biliary tract, ovary, pancreas, esophagus, endometrium, and head & neck. It also complements existing screening strategies for breast, colorectal, and lung cancers. With this successful validation, Gene Solutions is moving forward with plans to integrate SPOT-MAS into daily clinical practice. The company is collaborating with leading hospitals, regulators, and research institutions to expand access and adoption in both public and private healthcare sectors. As shared in a recent interview with GenomeWeb(8), Dr. Tran Le Son, R&D Lead at Gene Solutions, outlined the upcoming plans for the technology: Ongoing and Planned Studies: Gene Solutions is conducting and planning several additional studies, including a multicenter validation study similar to K-DETEK but focused on symptomatic individuals suspected of having cancer. "In this study, we aim to validate the test's effectiveness in a high-risk diagnostic population. We plan to complete the study and submit a manuscript by the end of this year," Dr. Tran explained. SPOT-MAS Lung and SPOT-MAS CRC: Another multicenter validation study is planned in Singapore to assess the effectiveness of the SPOT-MAS Lung test in detecting lung cancer in both screening and diagnostic populations. Like the SPOT-MAS MCED test, the single-cancer assays analyze ctDNA for genetic, fragmentomic, and epigenetic features, with an optimized focus on signals specific to lung cancer or colorectal cancer. The single-cancer approach is expected to offer significant clinical advantages in specific scenarios. For instance, when a specific cancer is strongly suspected, a test tailored exclusively for that cancer will be more cost-effective and deliver superior screening performance, such as higher sensitivity and specificity, compared to broader screening methods. Biopharma Collaborations: "Looking ahead, we are eager to collaborate more with biopharma companies," Dr. Tran shared. Gene Solutions aims to leverage its proprietary artificial intelligence platform and Asia-centric genomic advantages to discover biomarkers and therapeutic targets for personalized cancer treatments and cancer vaccines. About Gene SolutionsGene Solutions, a multinational biotech company in Asia, is leading the way in leveraging advanced AI and ctDNA technologies for innovative cancer detection solutions. The company partners with over 4,500 hospitals and clinics across Southeast Asia and boasts a team of approximately 250 biology experts and technicians out of a total of 700 employees. Gene Solutions has published more than 50 peer-reviewed publications and conducted over 50 multi-center studies across the region. The company, recognized for its proprietary research and CAP-accredited laboratories in Singapore and Vietnam, combines multi-dimensional genomics with AI-driven approaches to transform cancer care. References:(1) Statistics adapted from the American Cancer Society's (ACS) publication, Cancer Facts & Figures 2022 and Cancer Facts & Figures 2021; the ACS website; and the International Agency for Cancer Research website. (2) Sankaranarayanan, R., Ramadas, K., Qiao, Y., 2014. Managing the changing burden of cancer in Asia. BMC Med 12, 3. (3) Imai, M., Nakamura, Y., & Yoshino, T. (2025). Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies. International Journal of Clinical Oncology.(4) Le Son Tran et al (2023) Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization eLife 12:RP89083. (5) Nguyen, L. H. D., et al. (2025). Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Medicine, 23(1). (6) Annals of Oncology (2024) 35 (suppl_4): S1679-S1697. (7) Carbonell, Chantelle, et al. Cancer Control 31 (2024).(8) Genomeweb.com Gene Solutions Looks to Expand MCED Test Market After Strong Validation Data (19 Feb 2025).
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
